Pakistan and China have signed multiple agreements and memoranda of understanding to expand cooperation in construction machinery, livestock health, and ...

Nigerian student Owoeye Daniella achieves top score with over 370 in the 2026 UTME, as DailyEd Tutorials celebrates a ...

Biotech has benefited marginally from this rotation. Value beat growth notably in the first quarter. The energy sector was obviously the best performing of the 11 sectors of the S&P 500 in Q1 with a ...

When Gossamer Bio announced poor results from its flagship blood pressure study in February, the San Diego company’s stock dropped by 78% in value. Now, it’s slashing its staff. The biotech lab began ...

METRO COMMUNITY COLLEGE CELEBRATES ITS NEW BIOTECHNOLOGY PROGRAM. IT’S. IT’S LAUNCHING AT THE ELKHORN CAMPUS AS KETV NEWSWATCH 7 SCHUYLER REPORTS, THE GOAL IS TO GET STUDENTS READY FOR A RAPIDLY ...

Molecular glue-focused biotech f5 Therapeutics has failed to stick around for the long haul, shuttering after six years, according to an announcement from the company’s CEO on LinkedIn. “The past few ...

These companies will offer you the fantastic combination of growth and safety. They're both trading at reasonable prices right now. Biotech stocks may offer your portfolio an element of growth, and ...

The National Security Commission on Emerging Biotechnology is visiting Pittsburgh to talk about how biotechnology and artificial intelligence will play a role in the city.Carnegie Mellon University ...

Lizzi C. Lee is a fellow on the Chinese economy at Asia Society Policy Institute’s Center for China Analysis (CCA), based in Washington DC, USA. Jing Qian is vice-president of the Asia Society and ...

Why personalized gene editing, genetic resurrections and embryo scoring made our list. Earlier this week, MIT Technology Review published its annual list of Ten Breakthrough Technologies. As always, ...

The green shoots suggesting a comeback was in sight for biotech stocks last year have mostly grown into proverbial flowering plants—but one company’s precipitous year-over-year decline in market ...

Some of the best-selling drugs in the world are facing a loss of exclusivity in key jurisdictions in the upcoming years in what the sector calls "the patent cliff." The need for pharma to top up their ...